Latest News about MRK
Recent news which mentions MRK
   2 Dividend Stocks Billionaires Are Buying: Should You?
   
  
  
  June 07, 2024
  From Motley Fool
 From InvestorPlace
 
   Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
   
  
  
  June 04, 2024
  From Benzinga
 
   Comparative Study: Merck & Co And Industry Competitors In Pharmaceuticals Industry
   
  
  
  June 04, 2024
  From Benzinga
 
   Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients
   
  
  
  June 03, 2024
  From Benzinga
 From Benzinga
 From InvestorPlace
 
   Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence
   
  
  
  May 29, 2024
  From Benzinga
 From Benzinga
 From Benzinga
 
   AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report
   
  
  
  May 27, 2024
  From Benzinga
 From Benzinga
 From Motley Fool
 From InvestorPlace
 From Benzinga
 From Benzinga
 From InvestorPlace
 From Benzinga
 From Benzinga
 
   Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma Treatment
   
  
  
  May 13, 2024
  From Benzinga
 From Benzinga
 From InvestorPlace
 From InvestorPlace
 From InvestorPlace
 From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
